1-9 of 9
C Haioun
Close
Sort by
Journal Articles

FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

Clinical Trials & Observations
R.-O. Casasnovas, L. Ysebaert, C. Thieblemont, E. Bachy, P. Feugier, A. Delmer, S. Tricot, J. Gabarre, M. Andre, C. Fruchart, N. Mounier, R. Delarue, M. Meignan, A. Berriolo-Riedinger, S. Bardet, J.-F. Emile, J.-P. Jais, C. Haioun, H. Tilly, F. Morschhauser
Journal: Blood
Blood (2017) 130 (11): 1315–1326.
https://doi.org/10.1182/blood-2017-02-766691
Published: 2017
Includes: Supplemental data
Journal Articles

Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission

E. Bachy, P. Brice, M. Fournier, H. Tilly, C. Haioun, N. Brousse, S. Le Gouil, A. Bosly, B. Coiffier, C. Gisselbrecht, P. Solal-Celigny, G. Salles
Journal: Blood
Blood (2008) 112 (11): 2590.
https://doi.org/10.1182/blood.V112.11.2590.2590
Published: 2008
Journal Articles

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study.

R. Delarue, N. Mounier, C. Haioun, B. Coiffier, C. Gisselbrecht, H. Ghesquieres, P. Lederlin, M. Blanc, C. Recher, O. Hermine, F. Reyes, H. Tilly, A. Bosly
Journal: Blood
Blood (2006) 108 (11): 2436.
https://doi.org/10.1182/blood.V108.11.2436.2436
Published: 2006
Journal Articles

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

B. Coiffier, C. Haioun, N. Ketterer, A. Engert, H. Tilly, D. Ma, P. Johnson, A. Lister, M. Feuring- Buske, J.A. Radford, R. Capdeville, V. Diehl, F. Reyes
Journal: Blood
Blood (1998) 92 (6): 1927–1932.
https://doi.org/10.1182/blood.V92.6.1927
Published: 1998
Journal Articles

CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas [see comments]

JF Emile, ML Boulland, C Haioun, P Kanavaros, T Petrella, MH Delfau-Larue, A Bensussan, JP Farcet, P Gaulard
Journal: Blood
Blood (1996) 87 (4): 1466–1473.
https://doi.org/10.1182/blood.V87.4.1466.bloodjournal8741466
Published: 1996
Journal Articles

Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

O Hermine, C Haioun, E Lepage, MF d'Agay, J Briere, C Lavignac, G Fillet, G Salles, JP Marolleau, J Diebold, F Reyas, P Gaulard
Journal: Blood
Blood (1996) 87 (1): 265–272.
https://doi.org/10.1182/blood.V87.1.265.265
Published: 1996
Journal Articles

Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma

Y Bastion, P Brice, C Haioun, A Sonet, G Salles, JP Marolleau, D Espinouse, F Reyes, C Gisselbrecht, B Coiffier
Journal: Blood
Blood (1995) 86 (8): 3257–3262.
https://doi.org/10.1182/blood.V86.8.3257.3257
Published: 1995
Journal Articles

Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta

JP Farcet, P Gaulard, JP Marolleau, JP Le Couedic, T Henni, MF Gourdin, M Divine, C Haioun, S Zafrani, M Goossens
Journal: Blood
Blood (1990) 75 (11): 2213–2219.
https://doi.org/10.1182/blood.V75.11.2213.2213
Published: 1990
Journal Articles

Comparison of genetic probe with immunophenotype analysis in lymphoproliferative disorders: a study of 87 cases

T Henni, P Gaulard, M Divine, JP Le Couedic, D Rocha, C Haioun, Z Henni, JP Marolleau, Y Pinaudeau, M Goossens
Journal: Blood
Blood (1988) 72 (6): 1937–1943.
https://doi.org/10.1182/blood.V72.6.1937.1937
Published: 1988